H3K27me3 is of prognostic significance in our AML cohort with worse outcomes overall and in particular subgroups, i.e. intermediate and unfavorable AML, IDH1, ASXL1, BCOR, U2AF1 and SRSF2 mutated patients. The gene discussed is BCOR; the disease is acute myeloid leukemia.